Dimensional Fund Advisors
SNOA icon

Dimensional Fund Advisors’s Sonoma Pharmaceuticals SNOA Stock Holding History

Dimensional Fund Advisors’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-750
Closed -$68K – 3552
2021
Q4 		$68K Buy
750
+186
+33% +$19.9K ﹤0.01% 3466
2021
Q3 		$63K Buy
+564
New +$69.4K ﹤0.01% 3460
2015
Q1 		– Sell
-4
Closed -$5K – 3389
2014
Q4 		$5K Hold
4
– – ﹤0.01% 3479
2014
Q3 		$8K Hold
4
– – ﹤0.01% 3492
2014
Q2 		$10K Hold
4
– – ﹤0.01% 3537
2014
Q1 		$12K Hold
4
– – ﹤0.01% 3532
2013
Q4 		$11K Hold
4
– – ﹤0.01% 3494
2013
Q3 		$9K Hold
4
– – ﹤0.01% 3535
2013
Q2 		$9K Buy
+4
New +$14.3K ﹤0.01% 3533

Other funds holding SNOA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HFS
HBC Financial Services Seattle, Washington $163M AUM 14.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Dimensional Fund Advisors's SNOA Position: Q1 2022 in Review

Dimensional Fund Advisors sold out of Sonoma Pharmaceuticals (SNOA) in Q1 2022, closing a stake of 750 shares — an estimated $68K sold.

Dimensional Fund Advisors first reported a position in SNOA in Q2 2013 and held it in 9 quarters. The position peaked at $68K in Q4 2021. 18 funds tracked by Wall St. Rank hold SNOA as of Q1 2022.

  • Dimensional Fund Advisors reported no remaining Sonoma Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 750 Sonoma Pharmaceuticals shares in Q1 2022, an estimated $68K.
  • Dimensional Fund Advisors first reported a position in Sonoma Pharmaceuticals in Q2 2013 and held it in 9 quarters.
  • Dimensional Fund Advisors's Sonoma Pharmaceuticals position peaked at $68K in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2022.

Based on Dimensional Fund Advisors's 13F filing for Q1 2022, filed 13 May 2022.